Published by Josh White on 11th April 2022
(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.
URL: http://www.digitallook.com/dl/news/story/32597887/...